![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Eurofins’ COVID-19 Test Gets European Clearance
Eurofins’ COVID-19 Test Gets European Clearance
![Eurofins logo](https://www.fdanews.com/ext/resources/test/Device_Images6/Eurofins-logo.gif?t=1613167398&width=430)
February 16, 2021
Eurofins has gained the CE mark for its serological SARS-CoV-2 assay, an enzyme-linked immunosorbent assay (ELISA) kit.
The company’s GSD NovaLisa SARS-CoV-2 quantitative IgG antibody test detects antibodies generated either by a vaccination or a natural infection.
Eurofins said that the test can distinguish between vaccinated patients and patients who had an asymptomatic infection before or after inoculation.
Upcoming Events
-
21Oct